Patent · US Active

Properdin binding protein and use thereof

US12162931B2 · kind B2 · utility

0Cited by

4References

23Claims

0Family size

Assignee

LINNO PHARMACEUTICALS INC. · CN

Inventors

Zhaozhong Han · Franklin, US
Lingyu Li · Chongqing, CN
Mengfan PENG · Shanghai, CN
Haiyang Li · Shanghai, CN
Jun Luo · Belmont, US
Hongya PAN · Shanghai, CN

Key dates

Filing date	Sep 1, 2023
Grant date	Dec 10, 2024
Priority date	—
Expiry date	Sep 1, 2043

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4716
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides an isolated antigen binding protein. The isolated antigen binding protein can specifically bind to properdin. The present disclosure also provides an anti-properdin antibody and a preparation method and an application thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.